Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 17c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.79), $0.17 better than the analyst estimate of ($0.96).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c